Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
$1.68B
Dr. John M. Leonard M.D.
485.00
Cambridge, MA
May 06, 2016
-3.03
$-5.45
1.14
6.73
-1,212.19%
-3.38
0.85
1.84
41.37
6.73
-44.51%
-51.97%
Similar stocks (7)
Beam Therapeutics Inc.
BEAM
Sana Biotechnology, Inc.
SANA
Prime Medicine, Inc.
PRME
Ginkgo Bioworks Holdings, Inc.
DNA
Fate Therapeutics, Inc.
FATE
Editas Medicine, Inc.
EDIT
Caribou Biosciences, Inc.
CRBU
ETF Exposure (34)
Global X Genomics & Biotechnology ETF
GNOM
3.23%
ARK Innovation ETF
ARKK
2.19%
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
1.44%
Franklin Genomic Advancements ETF
HELX
0.52%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.39572%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.3934400066%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.173%
iShares Biotechnology ETF
IBB
0.16594%
iShares Russell 2000 Value ETF
IWN
0.11745%
iShares Morningstar Small-Cap Growth ETF
ISCG
0.06471%
iShares Russell 2000 ETF
IWM
0.05791%
Schwab U.S. Small-Cap ETF
SCHA
0.0567510925%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.053257%
ProShares Ultra Nasdaq Biotechnology
BIB
0.05076037368957527%
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
0.04297%
Dimensional U.S. Small Cap ETF
DFAS
0.04132589%
Vanguard Small Cap Index Fund
NAESX
0.04%
iShares Morningstar Small-Cap ETF
ISCB
0.03263%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.031%
Fidelity MSCI Health Care Index ETF
FHLC
0.02738176%
ALPS Medical Breakthroughs ETF
SBIO
0.0103%
ProShares Hedge Replication ETF
HDG
0.009011222118665153%
Dimensional U.S. Targeted Value ETF
DFAT
0.00419985%
Schwab U.S. Broad Market ETF
SCHB
0.0039834045%
iShares Russell 3000 ETF
IWV
0.00261%
Dimensional U.S. Equity ETF
DFUS
0.0022004399999999997%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.00203595%
Dimensional US Core Equity Market ETF
DFAU
7.733200000000001e-4%
Vanguard ESG U.S. Stock ETF
ESGV
0%
Goldman Sachs Innovate Equity ETF
GINN
0%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0%
John Hancock Multifactor Large Cap ETF
JHML
0%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Similar stocks (7)
Beam Therapeutics Inc.
BEAM
Sana Biotechnology, Inc.
SANA
Prime Medicine, Inc.
PRME
Ginkgo Bioworks Holdings, Inc.
DNA
Fate Therapeutics, Inc.
FATE
Editas Medicine, Inc.
EDIT
Caribou Biosciences, Inc.
CRBU
ETF Exposure (34)
Global X Genomics & Biotechnology ETF
GNOM
3.23%
ARK Innovation ETF
ARKK
2.19%
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
1.44%
Franklin Genomic Advancements ETF
HELX
0.52%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.39572%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.3934400066%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.173%
iShares Biotechnology ETF
IBB
0.16594%
iShares Russell 2000 Value ETF
IWN
0.11745%
iShares Morningstar Small-Cap Growth ETF
ISCG
0.06471%
iShares Russell 2000 ETF
IWM
0.05791%
Schwab U.S. Small-Cap ETF
SCHA
0.0567510925%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.053257%
ProShares Ultra Nasdaq Biotechnology
BIB
0.05076037368957527%
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
0.04297%
Dimensional U.S. Small Cap ETF
DFAS
0.04132589%
Vanguard Small Cap Index Fund
NAESX
0.04%
iShares Morningstar Small-Cap ETF
ISCB
0.03263%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.031%
Fidelity MSCI Health Care Index ETF
FHLC
0.02738176%
ALPS Medical Breakthroughs ETF
SBIO
0.0103%
ProShares Hedge Replication ETF
HDG
0.009011222118665153%
Dimensional U.S. Targeted Value ETF
DFAT
0.00419985%
Schwab U.S. Broad Market ETF
SCHB
0.0039834045%
iShares Russell 3000 ETF
IWV
0.00261%
Dimensional U.S. Equity ETF
DFUS
0.0022004399999999997%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.00203595%
Dimensional US Core Equity Market ETF
DFAU
7.733200000000001e-4%
Vanguard ESG U.S. Stock ETF
ESGV
0%
Goldman Sachs Innovate Equity ETF
GINN
0%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0%
John Hancock Multifactor Large Cap ETF
JHML
0%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%